Overview
DASCO HME provides home medical equipment focused on respiratory and sleep care, distributing and renting devices for oxygen therapy, CPAP/BiPAP sleep therapy, and nebulizers to patients at home. It serves a B2C market and collaborates with hospitals to support patient discharge and home-based care. Devices deliver oxygen and enable at-home therapy, while nebulizers turn liquid medications into inhalable mist, and sleep equipment maintains airway support during sleep. The company differentiates itself through its family-owned, multi-state presence, hospital partnerships, and a range of services like respiratory and sleep therapy programs and patient education, aiming to improve patient outcomes by making essential home therapies accessible and well-supported.
Work here?Claim your company
Simplify's take
What believers are saying
- The August 2026 Memorial Hermann joint venture adds Greater Houston volume and referral access.
- February 2026 Aultman acquisition expanded Northeast Ohio reach and reinforced hospital partnerships.
- Wilmington, Massachusetts office opened in 2026, extending service into New England.
What critics are saying
- Perry v. DASCO Home Medical Equipment remains active in Ohio federal court since 2019.
- DASCO's hospital-heavy model concentrates reimbursement and referral risk inside health-system decisions.
- A single payer contract loss can collapse branch economics and trigger rapid market exits.
What makes DASCO HME unique
- DASCO runs 37-plus locations across 12 states, combining local branches with centralized DME operations.
- On August 10, 2026, Memorial Hermann chose DASCO to manage its home medical equipment business.
- DASCO's respiratory and sleep focus matches hospital discharge workflows and recurring patient needs.
Help us improve and share your feedback! Did you find this helpful?